Use of standardised patients to assess antibiotic dispensing for tuberculosis by pharmacies in urban India: a cross-sectional study

The Lancet Infectious Diseases

Volumn 16, Issue 11, 2016, Pages 1261-1268

  Satyanarayana, Srinath ^a   Kwan, Ada ^c   Daniels, Benjamin ^c   Subbaraman, Ramnath ^d   McDowell, Andrew ^a   Bergkvist, Sofi ^e   Das, Ranendra K ^f   Das, Veena ^g   Das, Jishnu ^c,h   Pai, Madhukar ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MANIPAL UNIVERSITY   (India)

^c WORLD BANK   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e ACCESS Health International   (India)

^f Institute for Social and Economic Research on Development and Democracy   (India)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h Center for Policy Research   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; STEROID; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CASE MANAGEMENT; CLINICAL PHARMACY; CROSS-SECTIONAL STUDY; DRUG USE; HUMAN; INDIA; LUNG TUBERCULOSIS; NAMED GROUPS OF PERSONS; PATIENT REFERRAL; PHARMACIST; PRIORITY JOURNAL; SIMULATION; STANDARDIZED PATIENT; STEROID THERAPY; URBAN AREA; COUNSELING; DRUG MISUSE; PHARMACY; QUESTIONNAIRE; SUPPLY AND DISTRIBUTION; TUBERCULOSIS, PULMONARY;

ANTI-BACTERIAL AGENTS; COUNSELING; CROSS-SECTIONAL STUDIES; HUMANS; INDIA; PHARMACIES; PRESCRIPTION DRUG MISUSE; SURVEYS AND QUESTIONNAIRES; TUBERCULOSIS, PULMONARY;

EID: 84994812849     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(16)30215-8     Document Type: Article

References (29)

1. 1 Shallcross, LJ, Davies, SC, The World Health Assembly resolution on antimicrobial resistance. J Antimicrob Chemother 69 (2014), 2883–2885.
2. 2 Van Boeckel, TP, Gandra, S, Ashok, A, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis 14 (2014), 742–750.
3. 3 Levy, SB, Marshall, B, Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 10 (2004), S122–S189.
4. 4 Laxminarayan, R, Chaudhury, RR, Antibiotic resistance in India: drivers and opportunities for action. PLoS Med, 13, 2016, e1001974.
5. 5 Chen, T-C, Lu, P-L, Lin, C-Y, Lin, W-R, Chen, Y-H, Fluoroquinolones are associated with delayed treatment and resistance in tuberculosis: a systematic review and meta-analysis. Int J Infect Dis 15 (2011), e211–e226.
6. 6 Zhang, Y, Yew, W, Mechanisms of drug resistance in Mycobacterium tuberculosis [State of the art series. Drug-resistant tuberculosis. Edited by CY. Chiang. Number 1 in the series]. Int J Tuberc Lung Dis 13 (2009), 1320–1330.
7. 7 TB Care I. International standards for tuberculosis care, edn 3, 2014, TB CARE I, The Hague.
8. 8 WHO Country Office for India. Standards for tuberculosis Care in India, 2014, World Health Organization, Geneva.
9. 9 All India Organisation of Chemists and Druggists. All India Organisation of Chemists & Druggists history. http://www.aiocd.net/, 2015 (accessed Sept 24, 2015).
10. 10 Ministry of Health and Family Welfare, Government of India. The Drugs and Cosmetics Rules, 1945 [As amended up to 15th August, 2013]. http://www.mohfw.nic.in/WriteReadData/l892s/43503435431421382269.pdf (accessed Aug 15, 2016).
11. 11 Kotwani, A, Wattal, C, Joshi, P, Holloway, K, Irrational use of antibiotics and role of the pharmacist: an insight from a qualitative study in New Delhi, India. J Clin Pharm Ther 37 (2012), 308–312.
12. 12 Salunkhe, S, Pandit, V, Dawane, J, Sarda, K, More, C, Study of over the counter sale of antimicrobials in pharmacy outlets in Pune, India: a cross sectional study. Int J Pharm Bio Sci 4 (2013), 616–622.
13. 13 Kapoor, SK, Raman, AV, Sachdeva, KS, Satyanarayana, S, How did the tuberculosis patients reach DOTS services in Delhi? A study of patient treatment seeking behavior. PLoS One, 7, 2012, e42458.
14. 14 Goel, P, Ross-Degnan, D, Berman, P, Soumerai, S, Retail pharmacies in developing countries: a behavior and intervention framework. Soc Sci Med 42 (1996), 1155–1161.
15. 15 Central Tuberculosis Division. Tuberculosis India 2014: annual status report of the Revised National Tuberculosis Control Programme, 2014, Minstry of Health and Family Welfare, Government of India.
16. 16 Pai, M, Dewan, P, Testing and treating the missing millions with tuberculosis. PLoS Med, 12, 2015, e1001805.
17. 17 Udwadia, ZF, Amale, RA, Ajbani, KK, Rodrigues, C, Totally drug-resistant tuberculosis in India. Clin Infect Dis 54 (2012), 579–581.
18. 18 Government of India Ministry of Health and Family Welfare. Notification G.S.R. 588(E). Health, Do, (eds.), 2013, The Gazette of India Extraordinary, New Delhi.
19. 19 Government of India Ministry of Health and Family Welfare. National Formulary of India, 4th Edition, 2011, Indian Pharmacopoeia Commission, New Delhi.
20. 20 Das, J, Kwan, A, Daniels, B, et al. Use of standardised patients to assess quality of tuberculosis care: a pilot, cross-sectional study. Lancet Infect Dis 15 (2015), 1305–1313.
21. 21 Xu, T, de Almeida Neto, AC, Moles, RJ, A systematic review of simulated-patient methods used in community pharmacy to assess the provision of non-prescription medicines. Int J Pharm Pract 20 (2012), 307–319.
22. 22 Central TB Division Ministry of Health and Family Welfare, Government of India and Indian Pharmaceutical Association. Revised National Tuberculosis Control Programme training module for community pharmacists. http://www.pci.nic.in/Circulars/Training%20Module.pdf, 2013 (accessed Aug 15, 2016).
23. 23 Das, J, Holla, A, Das, V, Mohanan, M, Tabak, D, Chan, B, In urban and rural India, a standardized patient study showed low levels of provider training and huge quality gaps. Health Aff 31 (2012), 2774–2784.
24. 24 Cisneros, JR, Murray, KM, Corticosteroids in tuberculosis. Ann Pharmacother 30 (1996), 1298–1303.
25. 25 Kantele, A, Laaveri, T, Mero, S, et al. Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. Clin Infect Dis 60 (2015), 837–846.
26. 26 Torumkuney, D, Chaiwarith, R, Reechaipichitkul, W, et al. Results from the survey of antibiotic resistance (SOAR) 2012–14 in Thailand, India, South Korea and Singapore. J Antimicrob Chemother 71:suppl 1 (2016), i3–i19.
27. 27 Fardet, L, Petersen, I, Nazareth, I, Common infections in patients prescribed systemic glucocorticoids in primary care: a population-based cohort study. PLoS Med, 13, 2016, e1002024.
28. 28 Ghafur, A, Mathai, D, Muruganathan, A, et al. The Chennai Declaration: a roadmap to tackle the challenge of antimicrobial resistance. Indian J Cancer 50 (2013), 71–73.
29. 29 Kamat, VR, Nichter, M, Pharmacies, self-medication and pharmaceutical marketing in Bombay, India. Soc Sci Med 47 (1998), 779–794.